Murashko's 6C medicine plan Personalized care and AI

Oct 5

Murashko updates the 6C framework presented the previous year: genetic code and omics, phenotype imaging, biochemical markers, cellular systems, life context and AI calculation. He discusses gene treatments, earlier diagnosis of cancer and degenerative conditions, and individually appropriate nutrition, retaining warnings that supplements can help or harm. He reports a joint project involving Industry and Trade and Rostec to introduce digital morphology, claiming faster, more consistent diagnostic performance. He describes personal medical assistants supplying longitudinal information to medical records and big-data analysis for treatment and recommendations. These are a roadmap and progress claims, not proof that all services are universally deployed or that diagnosis is infallible.

Murashko updates his 6C medicine framework at BIOPROM: genetics and omics, phenotype imaging, biochemistry, cellular systems, life context and AI calculation. He describes personalized diagnosis and care, appropriate nutrition, digital morphology and medical assistants feeding data into records. He preserves benefit/harm qualifications for supplements and describes developments and intended uses, rather than universally deployed services or independently proven accuracy.